CARTO 3

· Biosense Webster, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CARTO 3, covering 2014-07-21 to 2014-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation

See pricing